- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Androgen receptor rediscovered: The new biology and targeting the androgen receptor therapeutically - Abstract
September 14, 2011
The combination of Serenoa repens, selenium and lycopene is more effective than Serenoa repens alone to prevent hormone dependent prostatic growth - Abstract
September 14, 2011
Association between saliva PSA and serum PSA in conditions with prostate adenocarcinoma - Abstract
September 13, 2011
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer - Abstract
September 13, 2011
The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance - Abstract
September 13, 2011
New treatment options for castrate-resistant prostate cancer: A urology perspective - Abstract
September 13, 2011
Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument - Abstract
September 13, 2011
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma and this response is associated with tumor growth and an unfavorable outcome - Abstract
September 13, 2011
Treatment options for localized prostate cancer - Abstract
September 13, 2011
Modified technique of robotic-assisted simple prostatectomy: Advantages of a vesico-urethral anastomosis - Abstract
September 12, 2011
The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy - Abstract
September 12, 2011
Benefits of whole ginger extract in prostate cancer - Abstract
September 12, 2011
Acute versus chronic exposure to androgen suppression for prostate cancer: Impact on the exercise response - Abstract
September 12, 2011
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer - Abstract
September 12, 2011
Outcome of antegrade radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level >100 ng/ml - Abstract
September 12, 2011